Medmix AGMDMXF 61 PS Ratio is 1.31 as of Jul. 12, 2026, which is 8% below its 10-year median of 1.42. GuruFocus rates MDMXF with a GF Score™ of 61/100 and a GF Value™ of $26.13. The stock has 7 warning signs investors should review. Among 3,023 Industrial Products companies, Medmix AG ranks better than 78.53% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Medmix AG's share price is $17.40.
Medmix AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $13.25. Hence, Medmix AG's PS Ratio for today is 1.31.
Good Sign:
Medmix AG stock PS Ratio (=0.75) is close to 5-year low of 0.71.
The historical rank and industry rank for Medmix AG's PS Ratio or its related term are showing as below:
MDMXF'
s PS Ratio Range Over the Past 10 Years
Min: 0.71 Med: 1.42 Max: 5.52
Current: 0.76
During the past 8 years, Medmix AG's highest PS Ratio was 5.52. The lowest was 0.71. And the median was 1.42.
MDMXF's PS Ratio is ranked better than 78.53% of 3023
companies
in the Industrial Products industry
Industry Median: 2.06
vs MDMXF: 0.76
Medmix AG revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue per Share Growth Rate of Medmix AG was -7.70% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -2.40% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 4.00% per year.
During the past 8 years, Medmix AG's highest 3-Year average Revenue per Share Growth Rate was 11.50% per year. The lowest was -2.40% per year. And the median was 1.70% per year.
Back to Basics: PS Ratio
Medmix AG (OTCPK:MDMXF) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Medmix AG PS Ratio Related Terms
Medmix AG PS Ratio Historical Data
* Premium members only.
The historical data trend for Medmix AG's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Industrial Machinery subindustry, Medmix AG's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medmix AG PS Ratio vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Medmix AG's PS Ratio distribution charts can be found below:
* The bar in red indicates where Medmix AG's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Medmix AG's Share Price of today is $17.40.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medmix AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $13.25.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Medmix AG (MDMXF) has a PS Ratio of 1.31 as of Jul. 12, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Medmix AG and its competitors. This is near median its historical median of 1.42. Over the past decade, Medmix AG's PS Ratio has ranged from 0.71 to 5.52. According to the industry distribution chart, Medmix AG ranks #649 out of 3023 companies in the Industrial Products industry, placing it in the top 21.5%.
Is Medmix AG's PS Ratio too high?
Medmix AG's current PS Ratio of 1.31 is near median its 10-year median of 1.42. Over the past 10 years, this metric has ranged from a low of 0.71 to a high of 5.52. The Industrial Products industry median PS Ratio is 2.06. Medmix AG's value of 1.31 is 36.4% below this industry median. Based on the distribution chart, Medmix AG ranks #649 out of 3023 companies in the Industrial Products industry, which is in the top quartile — a strong position relative to peers. Overall, Medmix AG has a GF Score™ of 61/100, reflecting its overall financial health beyond just this single metric.
How does Medmix AG's PS Ratio compare to GEV and ETN?
According to the Industrial Products industry distribution chart, Medmix AG ranks #649 out of 3023 companies for PS Ratio. This places Medmix AG in the top 22% of its industry — outperforming the majority of peers. The industry median PS Ratio is 2.06. Medmix AG's value of 1.31 is 36.4% below this benchmark. Historically, Medmix AG's own PS Ratio has ranged from 0.71 to 5.52 over the past decade. While the company's 10-year median is 1.42 vs. the industry median of 2.06, Medmix AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for an Industrial Products company?
The median PS Ratio among Industrial Products companies is 2.06, based on 3,023 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medmix AG's current PS Ratio of 1.31 is 36.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Medmix AG and its competitors. For the Industrial Products industry, the median PS Ratio is 2.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medmix AG's current PS Ratio is 1.31, which is near median its own 10-year median of 1.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medmix AG stock overvalued right now?
Medmix AG (MDMXF) has a current PS Ratio of 1.31. The stock's GF Value™ is $26.13, compared to a current price of $17.40 — trading 33.4% below its estimated fair value. The current PS Ratio is 1.31, which is near median its 10-year median of 1.42 and 36.4% below the Industrial Products industry median of 2.06. Medmix AG's overall GF Score™ is 61/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Medmix AG (MDMXF), the current PS Ratio is 1.31 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medmix AG (MDMXF) Overvalued in 2026?
Based on GuruFocus' analysis, Medmix AG stock appears to be undervalued.
The current stock price of $17.40 is trading 33.4% below its estimated GF Value™ of $26.13.
Key valuation signals for MDMXF:
PS Ratio: 1.31 (near median its 10-year median of 1.42)
GF Value™: $26.13 vs. price of $17.40 (33.4% below fair value)
Industry Position: 36.4% below the Industrial Products median (#649 of 3023)
No single metric tells the full story. See the MDMXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medmix AG designs and produces high-precision delivery devices for the healthcare, consumer and industrial segments. Its segments are Healthcare, Consumer & Industrial, and Others. The Healthcare segment focuses on delivery devices for the drug delivery, surgery, and dental markets, including injection pens for subcutaneous drug delivery, surgical delivery devices, and mixing and delivery systems for the dental consumable industry. The Consumer & Industrial segment focuses on delivery devices used for industrial applications such as adhesives in construction, electronics, automotive, and aerospace, as well as consumer markets such as beauty and microbrush applications. The company operates in Europe, the Middle East and Africa, the Americas, and Asia-Pacific.
61GF Score
Get the complete analysis for MDMXF
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MDMXF has been successfully added to your 
